Existing patients remain fully supported with uninterrupted care and refills. New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line drugs for obesity and most related complications. You’re really going to be interested in Henry as a Semaglutide provider when...

Continue reading